CI Financial (TSE:CIX – Get Free Report) had its price objective upped by Raymond James from C$27.00 to C$32.00 in a report released on Tuesday,BayStreet.CA reports. Raymond James’ target price suggests a potential upside of 2.99% from the stock’s current price.
CIX has been the subject of several other research reports. Scotiabank boosted their target price on shares of CI Financial from C$25.00 to C$26.00 in a research note on Friday, November 15th. BMO Capital Markets boosted their price objective on shares of CI Financial from C$22.00 to C$25.00 in a research report on Friday, November 15th. TD Securities downgraded CI Financial from a “buy” rating to a “sell” rating and lifted their target price for the company from C$28.00 to C$32.00 in a research note on Tuesday. Keefe, Bruyette & Woods increased their price target on CI Financial from C$21.00 to C$28.00 in a research report on Monday, November 18th. Finally, Jefferies Financial Group boosted their price objective on CI Financial from C$20.00 to C$27.00 and gave the company a “buy” rating in a research report on Friday, November 1st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of C$27.94.
Check Out Our Latest Research Report on CIX
CI Financial Price Performance
CI Financial Company Profile
CI Financial Corp. is a publicly owned asset management holding company. Through its subsidiaries, the firm manages separate client focused equity, fixed income, and alternative investments portfolios. It also manages mutual funds, hedge funds, and fund of funds for its clients through its subsidiaries.
See Also
- Five stocks we like better than CI Financial
- Bank Stocks – Best Bank Stocks to Invest In
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a buyback in stocks? A comprehensive guide for investors
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for CI Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI Financial and related companies with MarketBeat.com's FREE daily email newsletter.